宏诚集团有限公司（Sunzen Group Berhad，前称为Sunzen Biotech Berhad）公布截至2025年3月31日止第三季度业绩，受惠于贷款融资与医疗器材与服务板块的稳定表现，录得税前盈利192万令吉，营收达1,570万令吉。尽管集团已变更财政年结日期，无法与去年同期直接比较，但与上一季度（2025财年第二季度）相较，营收由2,735万令吉回落，税前盈利亦从289万令吉下滑。集团指出，此乃因节庆效应消退后健康产品需求恢复常态，加上早前中国新城疫预警导致燕窝出口短暂中断所致。目前相关限制已于2025年1月中旬解除，出口已恢复正常。阅读更多
8–10 May 2025 | Ames Hotel, MelakaTo strengthen cross-company synergy [...]
Sunzen Group celebrated the spirit of Ramadan with a heartwarming [...]
Ecolite Biotech held its Annual Dinner 2025 on 28 February [...]
KUALA LUMPUR: Sunzen Group Bhd posted a net profit of [...]
KUALA LUMPUR (Feb 18): Sunzen Group Bhd announced it is selling [...]
On 10 February 2025, Ecolite Biotech ushered in the Lunar [...]
On 24 January 2025, Ecolite Biotech held a lively and [...]
Sunzen Group celebrated Chinese New Year at Tung Yuen Chinese [...]
[prisna-wp-translate-show-hide behavior="show" except=""][/prisna-wp-translate-show-hide]On January 20, 2025, the teams from Finsource, [...]
Copyright © 2022 Sunzen Group Berhad (formerly known as Sunzen Biotech Berhad)
(200501003843 (680889-W)). All rights reserved.
